BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Harvard Business School
Argus Health
Baxter
Fish and Richardson
Fuji
McKesson
Federal Trade Commission
Mallinckrodt
McKinsey

Generated: January 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,731,296

« Back to Dashboard

Summary for Patent: 5,731,296
Title: Selective vasodilation by continuous adenosine infusion
Abstract:This invention is concerned with the use of adenosine as an agent for the treatment of human beings. More particularly, this invention is concerned with the administration of adenosine to human patients by continuous intravenous infusion for, inter alia, control of blood pressure, use as a selective vasodilator, decreasing pulmonary vascular resistance, treating acute pulmonary hypertension in conjunction with idiopathic respiratory distress syndrome, in diagnosing pulmonary hypertension in conjunction with cardiac septum defects, in percutaneous transluminal angioplasty (PTCA), in coronary thrombolysis (CTL) and in radionucleide scintography.
Inventor(s): Sollevi; Alf (Bromma, SE)
Assignee: Item Development AB (Stocksund, SE)
Application Number:08/031,666
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 5,731,296

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,731,296

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 176154 ➤ Subscribe
Austria 84419 ➤ Subscribe
Australia 5065585 ➤ Subscribe
Australia 613304 ➤ Subscribe
Canada 1301652 ➤ Subscribe
Germany 19975044 ➤ Subscribe
Germany 3586993 ➤ Subscribe
Germany 3588205 ➤ Subscribe
Germany 3590855 ➤ Subscribe
Denmark 253187 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Julphar
Queensland Health
Covington
Medtronic
Moodys
Harvard Business School
Chubb
Dow
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot